Page 12«..11121314..2030..»

Why the sci-fi dream of cryonics never died – MIT Technology Review

The environment was something of a shift for Drake, who had spent the previous seven years as the medical response director of the Alcor Life Extension Foundation. Though it was the longtime leader in cryonics, Alcor was still a small nonprofit. It had been freezing the bodies and brains of its members, with the idea of one day bringing them back to life, since 1976.

The foundation, and cryonics in general, had long survived outside of mainstream acceptance. Typically shunned by the scientific community, cryonics is best known for its appearance in sci-fi films like 2001: A Space Odyssey. But its adherents have held on to a dream that at some point in the future, advances in medicine will allow for resuscitation and additional years on Earth. Over decades, small, tantalizing developments in related technology, as well as high-profile frozen test subjects like Ted Williams, have kept the hope alive. Today, nearly 200 dead patients are frozen in Alcors cryogenic chambers at temperatures of 196 C, including a handful of celebrities, who have paid tens of thousands of dollars for the goal of possible revival and ultimately reintegration into society.

But its the recent involvement of Yinfeng that signals something of a new era for cryonics. With impressive financial resources, government support, and scientific staff, its one of a handful of new labs focused on expanding the consumer appeal of cryonics and trying anew to bring credibility to the long-disputed theory of human reanimation. Just a year after Drake came on board as research director of the Shandong Yinfeng Life Science Research Institute, the subsidiary of the Yinfeng Biological Group overseeing the cryonics program, the institute performed its first cryopreservation. Its storage vats now hold about a dozen clients who are paying upwards of $200,000 to preserve the whole body.

Still, the field remains rooted in faith rather than any real evidence that it works. Its a hopeless aspiration that reveals an appalling ignorance of biology, says Clive Coen, a neuroscientist and professor at Kings College London.

Even if one day you could perfectly thaw a frozen human body, you would still just have a warm dead body on your hands.

The cryonics process typically goes something like this: Upon a persons death, a response team begins the process of cooling the corpse to a low temperature and performs cardiopulmonary support to sustain blood flow to the brain and organs. Then the body is moved to a cryonics facility, where an organ preservation solution is pumped through the veins before the body is submerged in liquid nitrogen. This process should commence within one hour of deaththe longer the wait, the greater the damage to the bodys cells. Then, once the frozen cadaver is ensconced in the cryogenic chamber, the hope of the dead begins.

Since its beginnings in the late 1960s, the field has attracted opprobrium from the scientific community, particularly its more respectable cousin cryobiologythe study of how freezing and low temperatures affect living organisms and biological materials. The Society for Cryobiology even banned its members from involvement in cryonics in the 1980s, with a former society president lambasting the field as closer to fraud than either faith or science.

In recent years, though, it has grabbed the attention of the libertarian techno-optimist crowd, mostly tech moguls dreaming of their own immortality. And a number of new startups are expanding the playing field. Tomorrow Biostasis in Berlin became the first cryonics company in Western Europe in 2019, for example, and in early 2022, Southern Cryonics opened a facility in Australia.

More researchers are open to longer-term, futuristic topics than there might have been 20 years ago or so, says Tomorrow Biostasis founder Emil Kendziorra.

Here is the original post:
Why the sci-fi dream of cryonics never died - MIT Technology Review

Recommendation and review posted by Bethany Smith

International Cryonics Museum has been chosen as the Sight of the Week by the editors of Roadside America. – Estes Park Trail-Gazette

International Cryonics Museum has been chosen as the Sight of the Week by the editors of Roadside America.  Estes Park Trail-Gazette

More:
International Cryonics Museum has been chosen as the Sight of the Week by the editors of Roadside America. - Estes Park Trail-Gazette

Recommendation and review posted by Bethany Smith

In case you missed it, link below to the CBS Sunday Morning segment about the Cryonics Museum – Estes Park Trail-Gazette

In case you missed it, link below to the CBS Sunday Morning segment about the Cryonics Museum  Estes Park Trail-Gazette

Read more:
In case you missed it, link below to the CBS Sunday Morning segment about the Cryonics Museum - Estes Park Trail-Gazette

Recommendation and review posted by Bethany Smith

Growth of the U.S. DTC Genetic Testing Market | Personalized Nutrition Medicine – Medriva

Growth of the U.S. DTC Genetic Testing Market | Personalized Nutrition Medicine  Medriva

Here is the original post:
Growth of the U.S. DTC Genetic Testing Market | Personalized Nutrition Medicine - Medriva

Recommendation and review posted by Bethany Smith

Abu Dhabi Stem Cells Center partners with Japan-based Kyoto University and Rege Nephro – ZAWYA

Abu Dhabi Stem Cells Center partners with Japan-based Kyoto University and Rege Nephro  ZAWYA

The rest is here:
Abu Dhabi Stem Cells Center partners with Japan-based Kyoto University and Rege Nephro - ZAWYA

Recommendation and review posted by Bethany Smith

Abu Dhabi Stem Cells Centre partners with Rege Nephro and Kyoto University’s Center for iPS Cell Research and … – Abu Dhabi Media Office

Abu Dhabi Stem Cells Centre partners with Rege Nephro and Kyoto University's Center for iPS Cell Research and ...  Abu Dhabi Media Office

Read more:
Abu Dhabi Stem Cells Centre partners with Rege Nephro and Kyoto University's Center for iPS Cell Research and ... - Abu Dhabi Media Office

Recommendation and review posted by Bethany Smith

Donating Bone Marrow and Stem Cells: The Process and What To Expect – On Cancer – Memorial Sloan Kettering

Donating Bone Marrow and Stem Cells: The Process and What To Expect  On Cancer - Memorial Sloan Kettering

Excerpt from:
Donating Bone Marrow and Stem Cells: The Process and What To Expect - On Cancer - Memorial Sloan Kettering

Recommendation and review posted by Bethany Smith

Effects of fine particulate matter on bone marrow-conserved hematopoietic and mesenchymal stem cells: a systematic … – Nature.com

Effects of fine particulate matter on bone marrow-conserved hematopoietic and mesenchymal stem cells: a systematic ...  Nature.com

See original here:
Effects of fine particulate matter on bone marrow-conserved hematopoietic and mesenchymal stem cells: a systematic ... - Nature.com

Recommendation and review posted by Bethany Smith

Hematopoietic Stem Cell Transplantation Market to Grow Rapidly During the Study Period (2019-2032), Evaluates … – Yahoo Finance

Hematopoietic Stem Cell Transplantation Market to Grow Rapidly During the Study Period (2019-2032), Evaluates ...  Yahoo Finance

See original here:
Hematopoietic Stem Cell Transplantation Market to Grow Rapidly During the Study Period (2019-2032), Evaluates ... - Yahoo Finance

Recommendation and review posted by Bethany Smith

The Key to Creating Blood Stem Cells May Lie in Your Own Blood – ScienceAlert

The Key to Creating Blood Stem Cells May Lie in Your Own Blood  ScienceAlert

More:
The Key to Creating Blood Stem Cells May Lie in Your Own Blood - ScienceAlert

Recommendation and review posted by Bethany Smith

Garuda Therapeutics to Present at the 42nd Annual J.P. Morgan Healthcare Conference – Yahoo Finance

Garuda Therapeutics to Present at the 42nd Annual J.P. Morgan Healthcare Conference  Yahoo Finance

Continued here:
Garuda Therapeutics to Present at the 42nd Annual J.P. Morgan Healthcare Conference - Yahoo Finance

Recommendation and review posted by Bethany Smith

The role of graft T-cell size in patients receiving alemtuzumab serotherapy for non-malignant disorders: results of an … – Nature.com

The role of graft T-cell size in patients receiving alemtuzumab serotherapy for non-malignant disorders: results of an ...  Nature.com

Link:
The role of graft T-cell size in patients receiving alemtuzumab serotherapy for non-malignant disorders: results of an ... - Nature.com

Recommendation and review posted by Bethany Smith

A California Man With Leukemia Has a Perfect Match for Bone Marrow Donation. But the US Isn’t Letting His Cousin … – The Messenger

A California Man With Leukemia Has a Perfect Match for Bone Marrow Donation. But the US Isn't Letting His Cousin ...  The Messenger

Go here to see the original:
A California Man With Leukemia Has a Perfect Match for Bone Marrow Donation. But the US Isn't Letting His Cousin ... - The Messenger

Recommendation and review posted by Bethany Smith

Attitude, Practices, and Barriers to Menopausal Hormone Therapy Among Physicians in Saudi Arabia – Cureus

Attitude, Practices, and Barriers to Menopausal Hormone Therapy Among Physicians in Saudi Arabia  Cureus

Go here to read the rest:
Attitude, Practices, and Barriers to Menopausal Hormone Therapy Among Physicians in Saudi Arabia - Cureus

Recommendation and review posted by Bethany Smith

Kris Tyson Showed Her Transformation One Year After Starting Hormone Replacement Therapy – Yahoo Entertainment

Kris Tyson Showed Her Transformation One Year After Starting Hormone Replacement Therapy  Yahoo Entertainment

See the original post here:
Kris Tyson Showed Her Transformation One Year After Starting Hormone Replacement Therapy - Yahoo Entertainment

Recommendation and review posted by Bethany Smith

Understanding Hypogonadism, Testosterone Replacement Therapy, and Prostate Cancer Risk – Medriva

Understanding Hypogonadism, Testosterone Replacement Therapy, and Prostate Cancer Risk  Medriva

See the original post here:
Understanding Hypogonadism, Testosterone Replacement Therapy, and Prostate Cancer Risk - Medriva

Recommendation and review posted by Bethany Smith

Arbor, 4DMT partner on new gene therapies in ALS, other diseases – ALS News Today

Arbor, 4DMT partner on new gene therapies in ALS, other diseases  ALS News Today

Read the original here:
Arbor, 4DMT partner on new gene therapies in ALS, other diseases - ALS News Today

Recommendation and review posted by Bethany Smith

Gene Therapy Approvals Expected to Ramp Up in 2024 Amid Manufacturing, Cost Challenges – BioSpace

Gene Therapy Approvals Expected to Ramp Up in 2024 Amid Manufacturing, Cost Challenges  BioSpace

Read more from the original source:
Gene Therapy Approvals Expected to Ramp Up in 2024 Amid Manufacturing, Cost Challenges - BioSpace

Recommendation and review posted by Bethany Smith

The year of gene therapy? FDA’s Marks calls for solutions to regulatory, manufacturing challenges – BioWorld Online

The year of gene therapy? FDA's Marks calls for solutions to regulatory, manufacturing challenges  BioWorld Online

See the original post:
The year of gene therapy? FDA's Marks calls for solutions to regulatory, manufacturing challenges - BioWorld Online

Recommendation and review posted by Bethany Smith

Turning On Gene Therapy with the pA Regulator – RegMedNet

Turning On Gene Therapy with the pA Regulator  RegMedNet

See the article here:
Turning On Gene Therapy with the pA Regulator - RegMedNet

Recommendation and review posted by Bethany Smith

Revolutionizing Healthcare: Gene Therapy Market Projected to Reach USD 46.5 billion by 2030 at a 22. – PharmiWeb.com

Revolutionizing Healthcare: Gene Therapy Market Projected to Reach USD 46.5 billion by 2030 at a 22.  PharmiWeb.com

Read the rest here:
Revolutionizing Healthcare: Gene Therapy Market Projected to Reach USD 46.5 billion by 2030 at a 22. - PharmiWeb.com

Recommendation and review posted by Bethany Smith

Regeneron CEO Reveals the Game-Changing Potential of Gene Therapy in Biotech! – BioTecNika

Regeneron CEO Reveals the Game-Changing Potential of Gene Therapy in Biotech!  BioTecNika

See more here:
Regeneron CEO Reveals the Game-Changing Potential of Gene Therapy in Biotech! - BioTecNika

Recommendation and review posted by Bethany Smith

Bayer’s AskBio checks off another early win for gene therapy platform with Parkinson’s safety data – FierceBiotech

Bayer's AskBio checks off another early win for gene therapy platform with Parkinson's safety data  FierceBiotech

Link:
Bayer's AskBio checks off another early win for gene therapy platform with Parkinson's safety data - FierceBiotech

Recommendation and review posted by Bethany Smith

What It Means That Lisa Rinna Is On HRT For Menopause – Women’s Health

What It Means That Lisa Rinna Is On HRT For Menopause  Women's Health

See more here:
What It Means That Lisa Rinna Is On HRT For Menopause - Women's Health

Recommendation and review posted by Bethany Smith

Lisa Rinna Was Initially ‘Very Scared’ of Hormone Replacement Therapy. She Isn’t the Only One – The Messenger

Lisa Rinna Was Initially 'Very Scared' of Hormone Replacement Therapy. She Isn't the Only One  The Messenger

More:
Lisa Rinna Was Initially 'Very Scared' of Hormone Replacement Therapy. She Isn't the Only One - The Messenger

Recommendation and review posted by Bethany Smith


Archives